4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-018594
Chief Medical Officer sold 150,000 shares at $19.84 ($2,976,000)
- Chief Medical Officer acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Solomons Neil Chief Medical Officer | 2021-09-13 | Option exercise | +150,000 | $3.20 | $480,000 | 287,299 | D: show line 1 in the form |
| Solomons Neil Chief Medical Officer | 2021-09-10 | Sale | −150,000 | $19.84 | $2,976,000 | 137,299 | D: show line 2 in the form |
| Open-market sales · 150,000 sh · avg $19.84 · $2,976,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Solomons Neil Chief Medical Officer | 2021-09-13 | Option exercise · Stock Option (right to buy) | −150,000 | 2,000 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_163165384671882.xml…